14-day Premium Trial Subscription Try For FreeTry Free

Vaccinex Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 96.30. In total, the insiders bought 38 158 191 and sold 15 774 VCNX shares in the last 100 trades.

Insider Power

(Last 100 transactions)
96.30
Buy 38 158 191 Shares
Sell 15 774 Shares

Historical Insider Trades

Date Type Action Person Amount
May 30, 2024 Common Stock Buy Friedberg Albert 861
May 29, 2024 Common Stock Buy Friedberg Albert 957
May 10, 2024 Stock Option (Right to Buy) Buy Yanni Barbara 10 108
May 10, 2024 Stock Option (Right to Buy) Buy Van Strydonck, Gerald E. 10 108
May 10, 2024 Common Stock Buy Van Strydonck, Gerald E. 543
May 10, 2024 Stock Option (Right to Buy) Buy Manian Bala S 10 108
May 10, 2024 Stock Option (Right to Buy) Buy Manian Bala S 2 685
May 10, 2024 Stock Option (Right to Buy) Buy Stecyk Chrystyna Bedrij 10 108
May 10, 2024 Stock Option (Right to Buy) Buy Frieberg Jacob B. 10 108
May 10, 2024 Stock Option (Right to Buy) Buy Frieberg Jacob B. 2 211
Apr 19, 2024 Common Stock Buy Friedberg Albert 282
Mar 28, 2024 Common Stock Buy Zauderer Maurice 38 610
Mar 28, 2024 Warrant (Right to Buy) Buy Zauderer Maurice 38 610
Mar 28, 2024 Common Stock Buy Friedberg Albert 102 960
Mar 28, 2024 Warrant (Right to Buy) Buy Friedberg Albert 102 960
Mar 21, 2024 Stock Option (Right to Buy) Buy Smith Ernest S. 1 341
Mar 21, 2024 Stock Option (Right to Buy) Buy Sanchez Jill 805
Mar 21, 2024 Stock Option (Right to Buy) Buy Evans Elizabeth E. 1 341
Mar 21, 2024 Stock Option (Right to Buy) Buy Zauderer Maurice 1 877
Mar 20, 2024 Stock Option (Right to Buy) Buy Evans Elizabeth E. 1 341
Mar 20, 2024 Stock Option (Right to Buy) Buy Smith Ernest S. 1 341
Mar 20, 2024 Stock Option (Right to Buy) Buy Sanchez Jill 805
Mar 20, 2024 Stock Option (Right to Buy) Buy Zauderer Maurice 1 877
Mar 14, 2024 Stock Option (Right to Buy) Buy Sanchez Jill 76
Mar 14, 2024 Stock Option (Right to Buy) Buy Sanchez Jill 38
Click to get the best stock tips daily for free!

About Vaccinex Inc.

Vaccinex. Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that completed and planned Phase 1b/2 clinical trials for the treatmen... VCNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT